121 related articles for article (PubMed ID: 1503645)
21. High susceptibility of transgenic rats carrying the human c-Ha-ras proto-oncogene to chemically-induced mammary carcinogenesis.
Tsuda H; Asamoto M; Ochiya T; Toriyama-Baba H; Naito A; Ota T; Sekiya T; Terada M
Mutat Res; 2001 Jun; 477(1-2):173-82. PubMed ID: 11376698
[TBL] [Abstract][Full Text] [Related]
22. Both (+/-)syn- and (+/-)anti-7,12-dimethylbenz[a]anthracene-3,4-diol-1,2-epoxides initiate tumors in mouse skin that possess -CAA- to -CTA- mutations at Codon 61 of c-H-ras.
Tang MS; Vulimiri SV; Viaje A; Chen JX; Bilolikar DS; Morris RJ; Harvey RG; Slaga TJ; DiGiovanni J
Cancer Res; 2000 Oct; 60(20):5688-95. PubMed ID: 11059761
[TBL] [Abstract][Full Text] [Related]
23. Heterozygous inactivation of TGF-beta1 increases the susceptibility to chemically induced mouse lung tumorigenesis independently of mutational activation of K-ras.
McKenna IM; Ramakrishna G; Diwan BA; Kang Y; Shiao YH; Wakefield LM; Powell DA; Anderson LM; Jakowlew SB
Toxicol Lett; 2001 Sep; 123(2-3):151-8. PubMed ID: 11641043
[TBL] [Abstract][Full Text] [Related]
24. Dibenzo[a,l]pyrene-induced DNA adduction, tumorigenicity, and Ki-ras oncogene mutations in strain A/J mouse lung.
Prahalad AK; Ross JA; Nelson GB; Roop BC; King LC; Nesnow S; Mass MJ
Carcinogenesis; 1997 Oct; 18(10):1955-63. PubMed ID: 9364006
[TBL] [Abstract][Full Text] [Related]
25. Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression.
Brown K; Buchmann A; Balmain A
Proc Natl Acad Sci U S A; 1990 Jan; 87(2):538-42. PubMed ID: 2105486
[TBL] [Abstract][Full Text] [Related]
26. Relationship between the formation of promutagenic adducts and the activation of the K-ras protooncogene in lung tumors from A/J mice treated with nitrosamines.
Belinsky SA; Devereux TR; Maronpot RR; Stoner GD; Anderson MW
Cancer Res; 1989 Oct; 49(19):5305-11. PubMed ID: 2670201
[TBL] [Abstract][Full Text] [Related]
27. Rare frequency of activation of the Ki-ras gene in rat colon tumors induced by heterocyclic amines: possible alternative mechanisms of human colon carcinogenesis.
Kakiuchi H; Ushijima T; Ochiai M; Imai K; Ito N; Yachi A; Sugimura T; Nagao M
Mol Carcinog; 1993; 8(1):44-8. PubMed ID: 8352890
[TBL] [Abstract][Full Text] [Related]
28. Carcinogenicity, metabolism and Ki-ras proto-oncogene activation by 7,12-dimethylbenz[a]anthracene in rainbow trout embryos.
Fong AT; Dashwood RH; Cheng R; Mathews C; Ford B; Hendricks JD; Bailey GS
Carcinogenesis; 1993 Apr; 14(4):629-35. PubMed ID: 8472326
[TBL] [Abstract][Full Text] [Related]
29. Induction of mammary cancer and lymphoma by multiple, low oral doses of 7,12-dimethylbenz[a]anthracene in SENCAR mice.
Qing WG; Conti CJ; LaBate M; Johnston D; Slaga TJ; MacLeod MC
Carcinogenesis; 1997 Mar; 18(3):553-9. PubMed ID: 9067556
[TBL] [Abstract][Full Text] [Related]
30. Cell-type-specific ras mutations but no microsatellite instability in chemically induced mouse skin tumors and transformed 3T3 cells.
Sasaki K; Bertrand O; Nakazawa H; Fitzgerald DJ; Mironov N; Yamasaki H
Cancer Res; 1995 Aug; 55(16):3513-6. PubMed ID: 7627957
[TBL] [Abstract][Full Text] [Related]
31. Murine p53 intron sequences 5-8 and their use in polymerase chain reaction/direct sequencing analysis of p53 mutations in CD-1 mouse liver and lung tumors.
Goodrow TL; Storer RD; Leander KR; Prahalada SR; van Zwieten MJ; Bradley MO
Mol Carcinog; 1992; 5(1):9-15. PubMed ID: 1543544
[TBL] [Abstract][Full Text] [Related]
32. Ki-ras and p53 mutations are early and late events, respectively, in urethane-induced pulmonary carcinogenesis in A/J mice.
Horio Y; Chen A; Rice P; Roth JA; Malkinson AM; Schrump DS
Mol Carcinog; 1996 Dec; 17(4):217-23. PubMed ID: 8989915
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of N-methyl-N-nitrosourea- and 7,12-dimethylbenz[a] anthracene-induced rat mammary tumorigenesis by dietary cholesterol is independent of Ha-Ras mutations.
El-Sohemy A; Archer MC
Carcinogenesis; 2000 Apr; 21(4):827-31. PubMed ID: 10753223
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Ki-ras gene mutation among simultaneously occurring multiple urethan-induced lung tumors in individual mice.
Ohmori H; Abe T; Hirano H; Murakami T; Katoh T; Gotoh S; Kido M; Kuroiwa A; Nomura T; Higashi K
Carcinogenesis; 1992 May; 13(5):851-5. PubMed ID: 1586998
[TBL] [Abstract][Full Text] [Related]
35. Skin tumorigenesis and Ki-ras and Ha-ras mutations in tumors from adult mice exposed in utero to 3'-azido-2',3'-dideoxythymidine.
Zhang Z; Diwan BA; Anderson LM; Logsdon D; Olivero OA; Haines DC; Rice JM; Yuspa SH; Poirier MC
Mol Carcinog; 1998 Sep; 23(1):45-51. PubMed ID: 9766437
[TBL] [Abstract][Full Text] [Related]
36. Ras gene mutations in 7,12-dimethylbenz[a]anthracene (DMBA)-induced rat sarcomas.
Walentinsson A; Levan G
Cancer Lett; 2001 May; 166(1):47-53. PubMed ID: 11295286
[TBL] [Abstract][Full Text] [Related]
37. Ki-ras mutation and cell proliferation of lung lesions induced by 1-nitropyrene in A/J mice.
Bai F; Nakanishi Y; Takayama K; Pei XH; Tokiwa H; Hara N
Mol Carcinog; 1998 Aug; 22(4):258-64. PubMed ID: 9726818
[TBL] [Abstract][Full Text] [Related]
38. Analysis of activated protooncogenes in B6C3F1 mouse liver tumors induced by ciprofibrate, a potent peroxisome proliferator.
Hegi ME; Fox TR; Belinsky SA; Devereux TR; Anderson MW
Carcinogenesis; 1993 Jan; 14(1):145-9. PubMed ID: 8425263
[TBL] [Abstract][Full Text] [Related]
39. Activation of H-ras oncogenes in preneoplastic mouse mammary tissues.
Kumar R; Medina D; Sukumar S
Oncogene; 1990 Aug; 5(8):1271-7. PubMed ID: 2118247
[TBL] [Abstract][Full Text] [Related]
40. Relationship between chemically induced Ha-ras mutation and transformation of BALB/c 3T3 cells: evidence for chemical-specific activation and cell type-specific recruitment of oncogene in transformation.
Nakazawa H; Aguelon AM; Yamasaki H
Mol Carcinog; 1990; 3(4):202-9. PubMed ID: 2119594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
